Australian Paediatric Surveillance Unit annual report, 2014
DOI:
https://doi.org/10.33321/cdi.2016.40.16Keywords:
Australia, paediatric surveillance, rare disease, paediatric communicable diseasesAbstract
The Australian Paediatric Surveillance Unit (APSU) was established in 1993 to facilitate national active surveillance of uncommon diseases of childhood including selected communicable diseases. This report includes data on the following conditions: acute flaccid paralysis (AFP), a surrogate condition for poliovirus infection; congenital cytomegalovirus (cCMV); congenital rubella; perinatal exposure to HIV and paediatric HIV infection; neonatal herpes simplex virus (HSV); congenital varicella; neonatal varicella; and juvenile onset recurrent respiratory papillomatosis (JoRRP). Surveillance of severe complications of influenza was undertaken during the influenza season (July to September 2014).
Downloads
References
Zurynski Y, McIntyre P, Booy R, Elliott EJ, Paeds Investigators Group. Paediatric active enhanced disease surveillance: a new surveillance system for Australia. J Paediatr Child Health 2013;49(7):588–594.
Australian Bureau of Statistics. 31010DO002_201409. Australian Demographic Statistics. September 2014. Canberra: Australian Bureau of Statistics: 2014
Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, et al. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol 2014;24(6):420–433.
Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015;372(10):933–943.
Dasari V, Smith C, Zhong J, Scott G, Rawlinson W, Khanna R. Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. J General Virol 2011;92(Pt 5):1021–1031.
Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang M-L, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009;360(12):1191–1199.
Khandaker G, Zurynski Y, Jones C. Surveillance for congenital rubella in Australia since 1993: Cases reported between 2004 and 2013. Vaccine 2014;32(50):6746–6751.
Jones CA, Raynes-Greenow C, Isaacs D, Neonatal HSV Study Investigators and Contributors to the Australian Paediatric Surveillance Unit. Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997–2011. Clin Infect Dis 2014;59(4):525–531.
Matys K, Malllary S, Bautista O, Vuocolo S, Manalastas R, Pitisuttithum P, et al. Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. Clin Vaccine Immunol 2012;19(6):881–885.
Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, et al. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2015;91(3):214–219.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2016 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
